Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/doxorubicin/prednisone/rituximab/vincristine

Known as: Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine, R-CHOP Regimen, Rituxan/CHOP 
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma and mantle cell lymphoma and is being studied in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ZusammenfassungDas diffuse großzellige B‑Zell-Lymphom („diffuse large B‑cell lymphoma“ –DLBCL) ist das häufigste Non-Hodgkin… 
2016
2016
目的 探讨手术联合化疗与单纯化疗对原发胃弥漫大B细胞淋巴瘤(PGDLBCL)患者生存的影响,并分析化疗过程中联合应用利妥昔单抗(R)对其预后的影响。 方法 回顾性分析83例PGDLBCL患者的临床资料,并分析外科手术及利妥昔单抗对患者生存的影响。 结果 83… 
2015
2015
Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) treatment failure is a… 
2008
2008
Posttransplant lymphoproliferative disorder (PTLD) is an uncommon but potentially fatal complication affecting 1% to 3% of renal… 
2006
2006
Authors conducted a one-year prospective study to determine whether CHOP regimen (cyclophosphamide, doxorubicin, vincristin, and… 
2006
2006
7537 Background: The combination of Rituximab (R) and CHOP is considered the standard of treatment for DLBCL in elderly patients… 
1994
1994
Background: The efficacy of chemotherapy protocols for the treatment of high-grade non-Hodgkin’s lymphoma (NHL) has not improved… 
1989
1989
A case of peripheral T-cell lymphoma presenting with secondary myelofibrosis and meningeal involvement is described. A 65-year… 
Review
1978
Review
1978
  • R. Benjamin
  • 1978
  • Corpus ID: 22810529
Adriamycin is now firmly established as a drug with a very broad spectrum of antitumor activity. It has had a major impact on the…